More than 6 in 10 U.S. abortions in 2023 done by medication, data shows
New research shows that more than six in 10 of the abortions in the U.S. last year were done through medication, up from 53% in 2020.
Watch CBS News
New research shows that more than six in 10 of the abortions in the U.S. last year were done through medication, up from 53% in 2020.
Following a pivotal FDA rule change, CVS and Walgreens will start offering the abortion pill, mifepristone, to individuals with prescriptions in states where abortion is legal. Dr. Celine Gounder, CBS News medical contributor and editor at large for public health at KFF, has more on what you need to know.
The two largest pharmacy chains in the U.S., CVS and Walgreens, will start selling the abortion pill mifepristone as soon as this month, the companies said Friday. Both companies were certified to dispense the pills following regulatory changes by the FDA. CBS News senior White House correspondent Weijia Jiang reports.
CVS and Walgreens say they will begin selling the abortion pill mifepristone in March. Lee Hasselbacher, research assistant professor at the University of Chicago, joins CBS News to discuss the move.
In January, the FDA changed regulations to allow retail pharmacies to sell the drug mifepristone.
Reproductive rights advocates Friday hailed a historic decision by Walgreens and CVS to begin dispensing the abortion pill mifepristone as soon as this month. The two pharmacy chains said the prescription pill will available in states where it's legal. Nikki Battiste has more.
The Supreme Court is set to decide whether or not it will block a ruling by a Texas federal judge that would limit access to mifepristone, a pill used in more than half of abortions nationwide. Jan Crawford reports.
American women who were not pregnant sent a European health service more than 48,000 requests for abortion drugs mifepristone and mifepristol from September 2021 through April 2023, according to a research letter published this week in the Journal of the American Medical Association. Laura Lindberg, a professor at the Rutgers School of Public Health, joined CBS News to discuss.
The Supreme Court announced Wednesday it will hear arguments on one case involving access to the abortion drug mifepristone and another case that could affect the charges against several Jan. 6 defendants and former President Donald Trump. CBS News chief legal correspondent Jan Crawford has more.
The Supreme Court is taking up two major cases, one involving regulation around the abortion drug mifepristone and the other reviewing a ruling involving the breadth of a federal obstruction law used to prosecute defendants in the Jan. 6, 2021, cases. CBS News chief legal correspondent Jan Crawford reports.
Danco Laboratories and the Justice Department asked the Supreme Court to review the appellate court's decision on patient access to the abortion pill.
A federal appeals court on Wednesday ruled in favor of limiting access to the abortion pill mifepristone. However, the new ruling won't go into effect due to a Supreme Court decision in April that halted the lower court's order as the appeals process plays out. CBS News legal contributor Jessica Levinson explained the legal process.
The law specifically aims to protect New York doctors who use telehealth systems to prescribe abortion pills for patients in states where abortion is banned.
The Biden administration faced skepticism from a conservative appeals court in New Orleans over its defense of the FDA's 2000 approval of the widely used abortion drug mifepristone. CBS News reporter Melissa Quinn has more.
Anti-abortion groups claim the FDA's green light of mifepristone forces them into situations where they must perform elective abortions.
The governor of North Carolina is railing against the state legislature's vote to override his veto of a ban on most abortions after 12 weeks. Meanwhile, a federal appeals court in New Orleans is hearing arguments Wednesday over the legal status of the abortion pill mifepristone. CBS News political correspondent Caitlin Huey-Burns has more.
The Supreme Court blocked a lower court ruling on Friday, allowing the abortion drug mifepristone to remain available during the appeals process. CBS News chief legal correspondent Jan Crawford reports from Alabama.
The Supreme Court on Friday maintained that the FDA's approval of mifepristone while the legal proceedings play out. Jan Crawford takes a look at what's next for the case, which is the most significant case involving abortion since Roe was overturned last year.
The Supreme Court on Friday preserved access to the abortion drug mifepristone while lower court proceedings continue.
The Supreme Court on Friday ruled that the Food and Drug Administration's approval of the abortion pill mifepristone can remain in place while legal proceedings play out. James Inman has the details.
The decision from the Supreme Court blocks lower court orders that would have restricted the availability of the abortion pill mifepristone nationwide.
The Supreme Court ruled Friday that the abortion pill mifepristone should remain available without restrictions — for now. The legal battle about whether the medication can remain on the market will continue. Willie James Inman reports.
The Supreme Court on Friday granted a Justice Department request to maintain the Food and Drug Administration's approval of the abortion drug mifepristone while legal proceedings continue. This comes after a lower court judge in Texas halted that FDA approval earlier this month. Jan Crawford has more.
The Supreme Court has maintained the FDA's approval of mifepristone, preserving access to the abortion pill for now. CBS News legal contributor Jessica Levinson has more.
The U.S. Supreme Court has until midnight Friday to rule on access to a widely used abortion pill. At issue is whether a lower court's restrictions on mifepristone can take effect or should be on hold during appeals. CBS News chief legal correspondent Jan Crawford joins us with more on the case.